Davis Lab

University of Arizona

PHARMACOLOGY

Tucson · United States

NIH-funded
Rate this labNo reviews yet — be the first.

Research focus

NIH R01 · 2024

Increased CNS Opioid Exposure by an Acetaminophen-Induced Blood-Brain Barrier Mechanism

PROJECT SUMMARY Over the past several years, we have studied changes in critical blood-brain barrier (BBB) tight junction (TJ) proteins (i.e., claudin-5, occludin) in response to diseases or drugs. Our work has shown that claudin-5 and occludin expression and trafficking is modulated by pain (i.e., TJ dysregulation), an effect that increases brain uptake of opioids such as codeine. Our preliminary data show that acetaminophen (APAP) can modulate expression of claudin-5 at the BBB and increase paracellular permeability (i.e., “leak”). Leak has previously been shown to occur with low dose, acute cocaine administration as well as methamphetamine. Both APAP and pain target transforming growth…

From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.

Reviews

← All labs at University of Arizona